Immuneering Corporation (IMRX)
NASDAQ·Healthcare·Biotechnology
$3.58
-2.72%
Mkt Cap $238.33M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$14.00
Range $11.00 – $17.00
Implied Upside
+291.1%
Consensus $14.00 vs current $3.58
NASDAQ·Healthcare·Biotechnology
$3.58
-2.72%
Mkt Cap $238.33M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$14.00
Range $11.00 – $17.00
+291.1%
Consensus $14.00 vs current $3.58